Graph Neural Network Drug Repurposing via PPI Diffusion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug repurposing methods lack reliable predictive power, leading to inefficient resource allocation and a 'winner-takes-all' pattern, where many potential drug candidates are overlooked, especially in the context of rapid drug development for pandemics like COVID-19, due to the high cost and extended timeline of full unbiased screening.
Innovation Solution
A multi-modal system incorporating a protein-protein interaction network, graph neural networks, diffusion modules, and proximity modules to predict effective drug candidates for treating diseases caused by pathogens, utilizing embedded representations, diffusion metrics, and proximity distances to generate ranked lists of candidate drugs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If full unbiased screening of all approved drugs is conducted, then all possible treatments can be identified, but the cost is high, timeline is extended, and success rate is low
Solution Approach 1:
The patent segments the drug identification process into multiple independent modules: graph neural network for embedding drugs and diseases in shared space, diffusion module for measuring network proximity, and proximity module for calculating shortest path distances. Each module processes different aspects of drug-disease relationships independently, then results are integrated to produce comprehensive rankings, enabling efficient yet thorough drug repurposing identification
Solution Approach 2:
The patent introduces an intermediary protein-protein interaction network that mediates between drugs and diseases. Instead of directly comparing all drug-disease pairs, the system uses the PPI network as an intermediary structure where drugs and diseases are mapped to protein targets, and relationships are inferred through network diffusion and proximity measurements, dramatically reducing computational complexity while maintaining identification completeness
2Productivity
If existing repurposing algorithms are used, then drug candidates can be ranked, but predictive power remains unknown because only a small subset is validated experimentally
Solution Approach 1:
The patent merges three distinct predictive approaches into a unified system: graph neural network embeddings capturing molecular similarity, diffusion-based network proximity measuring global network relationships, and shortest path proximity measuring local network distances. By combining these complementary methods, the system achieves higher predictive accuracy than any single method alone, as validated by experimental and clinical trial data
Solution Approach 2:
The patent incorporates feedback mechanisms where prediction results from each module inform and refine the overall ranking system. The aggregation module integrates results from graph neural network, diffusion, and proximity modules with weighted combinations, allowing the system to learn from validation outcomes and improve predictive power iteratively through experimental verification
3Reliability
If more drug candidates are tested, then better treatments can be found, but resources are siphoned away from testing a wider range of candidates due to winner-takes-all pattern
Solution Approach 1:
The patent changes the parameter of drug candidate evaluation from single-metric ranking to multi-dimensional scoring. Instead of relying on one algorithm to rank all drugs, the system evaluates drugs across multiple dimensions: graph neural network similarity scores, diffusion proximity metrics, and shortest path distances. This multi-parameter approach identifies a diverse set of high-priority candidates without concentrating resources on a single winner
Data Source
AI summary
Methods and systems for generating drug repurposing predictions for a disease caused by a pathogen, such as a novel pathogen, are provided. A multi-modal system includes a protein-protein interaction network (PPI), a graph neural network (GNN), a diffusion module, a proximity module, and an aggregation module. The GNN is configured to predict new edges between candidate drug nodes and disease nodes in an embedded representation of the PPI to produce a decoded embedding space. The diffusion module is configured to determine a proximity distance for pairs of nodes in the PPI, and the proximity module is configured to determine a proximity distance for pairs of nodes in the PPI, each pair comprising a pathogen-protein node and a drug-protein node. A ranked list of candidate drugs predicted to be effective in treatment of the disease based on candidate drug lists generated by the other modules is generated by the aggregation module.